Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

AXSM Axsome Therapeutics Inc

102,695

0,425 (0,42%)

Zuletzt aktualisiert: 17:02:56

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Axsome Therapeutics (NASDAQ:AXSM)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Axsome Therapeutics Charts.

Axsome Therapeutics (NASDAQ:AXSM)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Axsome Therapeutics Charts.

News Axsome Therapeutics Inc

Axsome Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18
Mittwoch 22 Januar 2025 (1 Tag vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 13 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue
Montag 13 Januar 2025 (1 Woche vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Montag 6 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 30 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer’s Disease Agitation
Montag 30 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 26 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in ENCORE Long-Term Phase 3 Trial in Narcolepsy
Dienstag 26 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 20 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 12 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Dienstag 12 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024
Freitag 8 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Axsome Therapeutics Inc News-Artikel

Trilogy International Pa...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen